C. Russell Trenary III, CEO and President at Outlook Therapeutics, Inc. (OTLK), bought 25,000 shares at $1.39 ($35K) on 2021-12-06, disclosed to the SEC on 2021-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EYE | SELL | 2009-02-26 | $1.9M | — | Filing → |
| EYE | SELL | 2008-06-03 | $24K | — | Filing → |
| EYE | SELL | 2007-05-04 | $82K | — | Filing → |